Demand Brands (DMAN) Stock Price, News & Analysis
Company Description
Demand Brands (OTC Link: DMAN) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $492.9K.
DMAN has gained 25.0% over the past year. Shares last traded at $0.0005.
This page collects what Stock Titan holds for DMAN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Demand Brands (DMAN) stock last traded at $0.0005. Over the past 12 months, the stock has gained 25.0%. At a market capitalization of $492.9K, DMAN is classified as a micro-cap stock with approximately 985.8M shares outstanding.
Latest News
Demand Brands has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all DMAN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Demand Brands (DMAN) currently stands at 198.3 thousand shares, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has decreased by 22.6%.
Days to Cover History
Days to cover for Demand Brands (DMAN) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 37.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.6 days.
DMAN Company Profile & Sector Positioning
Demand Brands (DMAN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DMAN often look at related companies in the same sector, including Gelstat Corp (GSAC), Cannlabs (CANL), Vibe Growth (VIBEF), Aequus Pharmaceu (AQSZF), and MAVEN BRANDS INC (TRLFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DMAN's relative position within its industry.